At Hologenix, LLC, we believe in the power of human potential. We innovate solutions that improve people’s health and well-being. Our flagship product, CELLIANT, is a bio-responsive infrared textile that transforms body heat into full-spectrum infrared energy and is clinically demonstrated to increase local circulation and cellular oxygenation. That means more energy and endurance, quicker recovery, and more restful sleep. CELLIANT is tested by a Science Advisory Board composed of experts in photobiology, nanotechnology, sleep medicine, and diabetes and wound care. They have overseen 9 peer-reviewed published studies that demonstrate CELLIANT'S effectiveness and the benefits of infrared energy. The FDA determined products containing CELLIANT are medical devices because they are intended to temporarily increase blood flow and local circulation at the site of application in healthy individuals. As part of the 513(g) submission process, the FDA reviewed and commented on appropriate health and wellness claims for CELLIANT products. The FDA has determined that CELLIANT products are medical devices as defined in section 201(h) of the Federal Food, Drug and Cosmetic Act and are general wellness products. The FDA has not approved or designated CELLIANT products for any purpose and has not made any determination about, or endorsement of, its stated use or benefits. CELLIANT is designated as a Class 1 Medical Device in Australia, Canada, the European Union, Japan, New Zealand, the United Arab Emirates and the United Kingdom. CELLIANT is cleared to market in China, India, Indonesia, Korea, Malaysia, Mexico, Peru, Philippines, Saudi Arabia, Singapore, South Africa, Taiwan, Thailand and Vietnam, with more countries and regions to follow. CELLIANT is used in performance and fashion apparel, as a textile in upholstered furniture, mattresses and bedding, as medical wraps and bandages for humans, horses, dogs and cats, and more. Est. 2002 in Pacific Palisades, CA.